Contact this trialFirst, we need to learn more about you.
Alkylating agents
Pembrolizumab + Chemotherapy for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
South Weymouth, Massachusetts
This trial is looking to see if a blood test can detect early response in patients being treated for lung cancer with pembrolizumab, and if so, whether patients should continue treatment with pembrolizumab or switch to pembrolizumab in combination with chemotherapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.